HAFKIN BARRY MD 4/A
4/A · ADVANCIS PHARMACEUTICAL CORP · Filed Jan 28, 2005
Insider Transaction Report
Form 4/AAmended
HAFKIN BARRY MD
SVP, Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2005-01-24+65,000→ 65,000 totalExercise: $4.05Exp: 2015-01-23→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]2.083% of the Options vest and become exercisable each month, commencing one month after February 15, 2005 (the "Initial Vesting Date") and on such day of every month thereafter, through the fourth anniversary of the Initial Vesting Date.